Page 267 - Read Online

Page 10 of 10 Gacad et al. Vessel Plus 2019;3:28 I http://dx.doi.org/10.20517/2574-1209.2019.011

68. Chatterjee S, Kundu A, Mukherjee D, Sardar P, Mehran R, et al. Risk of contrast-induced acute kidney injury in ST-elevation myocardial
infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using
observational data. Catheter Cardiovasc Interv 2017;90:205-12.
69. Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, et al. Hybrid coronary revftascularization versus coronary
artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg 2016;151:1081-9.
70. Kon ZN, Brown EN, Tran R, Joshi A, Reicher B, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity
compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 2008;135:367-75.
71. Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, et al. Simultaneous “hybrid” percutaneous coronary intervention and minimally
invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J 2008;155:661-7.
72. Giambruno V, Jones P, Khaliel F, Chu MW, Teefy P, et al. Hybrid coronary revascularization versus on-pump coronary artery bypass
grafting. Ann Thorac Surg 2018;105:1330-5.
73. Song Z, Shen L, Zheng Z, Xu B, Xiong H, et al. One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in
patients with diabetes mellitus. J Thorac Cardiovasc Surg 2016;151:1695-701.e1691.
74. Kayatta MO, Halkos ME, Puskas JD. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease. Ann
Cardiothorac Surg 2018;7:500-5.
75. Bonatti J, Schachner T, Bonaros N, Lehr EJ, Zimrin D, et al. Robotically assisted totally endoscopic coronary bypass surgery.
Circulation 2011;124:236-44.
76. Diegeler A, Walther T, Metz S, Falk V, Krakor R, et al. Comparison of MIDCAP versus conventional CABG surgery regarding pain and
quality of life. Heart Surg Forum 1999;2:290-5; discussion 295-6.
77. Verhaegh AJ, Accord RE, van Garsse L, Maessen JG. Hybrid coronary revascularization as a safe, feasible, and viable alternative to
conventional coronary artery bypass grafting: what is the current evidence?. Minim Invasive Surg 2013;2013:142616.
78. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, et al. Fractional flow reserve-guided PCI versus medical therapy in stable
coronary disease. N Engl J Med 2012;367:991-1001.
79. Green KD, Lynch DR Jr, Chen TP, Zhao D. Combining PCI and CABG: the role of hybrid revascularization. Curr Cardiol Rep
2013;15:351.
80. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, et al. Percutaneous coronary intervention versus coronary-artery
bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
81. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007;49:1600-6.
82. Head SJ, Kaul S, Mack MJ, Serruys PW, Taggart DP, et al. The rationale for Heart Team decision-making for patients with stable,
complex coronary artery disease. Eur Heart J 2013;34:2510-8.
83. Azzalini L, Torregrossa G, Puskas JD, Brilakis ES, Lombardi WL, et al. Percutaneous revascularization of chronic total occlusions:
rationale, indications, techniques, and the cardiac surgeon’s point of view. Int J Cardiol 2017;231:90-6.
84. Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, et al. Clinical outcomes of state-of-the-art percutaneous coronary revascularization
in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J 2017;38:3124-34.
85. Maeremans J, Walsh S, Knaapen P, Spratt JC, Avran A, et al. The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe:
The RECHARGE Registry. J Am Coll Cardiol 2016;68:1958-70.
86. Kufner S, Joner M, Thannheimer A, Hoppmann P, Ibrahim T, et al. Ten-year clinical outcomes from a trial of three Limus-eluting stents
with different polymer coatings in patients with coronary artery disease. Circulation 2019;139:325-33.
87. Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac
Cardiovasc Surg 1985;90:668-75.